Pulmonary vasculitis: diagnosis and treatment
- Authors: Anaev EK.1, Baranova IA1, Belevsky AS1
-
Affiliations:
- Pirogov Russian National Research Medical University
- Issue: Vol 90, No 3 (2018)
- Pages: 99-106
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32772
- DOI: https://doi.org/10.26442/terarkh201890399-106
- ID: 32772
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
E Kh Anaev
Pirogov Russian National Research Medical University
Email: el_anaev@hotmail.com
д.м.н., проф. каф. пульмонологии факультета дополнительного профессионального образования; ORCID iD 0000-0003-3672-9242 Moscow, Russia
I A Baranova
Pirogov Russian National Research Medical Universityд.м.н., проф., проф. кафедры госпитальной терапии педиатрического факультета, ORCID iD 0000-0002-2469-7346 Moscow, Russia
A S Belevsky
Pirogov Russian National Research Medical Universityд.м.н., проф., зав. каф. пульмонологии факультета дополнительного профессионального образования, ORCID iD 0000-0001-6050-724X Moscow, Russia
References
- Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, Höglund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K. European Vasculitis Study Group. Long - term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011; 70(3): 488-494. https://doi: 10.1136/ ard.2010.137778
- Jennette J.C, Falk R.J, Bacon P.A, Basu N, Cid M.C, Ferrario F, Flores-Suarez L.F, Gross W.L, Guillevin L, Hagen E.C, Hoffman G.S, Jayne D.R, Kallenberg C.G, Lamprecht P, Langford C.A, Luqmani R.A, Mahr A.D, Matteson E.L, Merkel P.A, Ozen S, Pusey C.D, Rasmussen N, Rees A.J, Scott D.G, Specks U, Stone J.H, Takahashi K, Watts R.A. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65(1): 1-11. https://doi: 10.1002/ art.37715
- Jennette J.C, Falk R.J, Andrassy K, Bacon P.A, Churg J, Gross W.L, Hagen E.C, Hoffman G.S, Hunder G.G, Kallenberg C.G et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994; 37(2): 187-192.
- Mandl L.A, Solomon D.H, Smith E.L, Lew R.A, Katz J.N, Shmerling R.H. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test - ordering guidelines improve diagnostic accuracy? Arch Intern Med. 2002; 162(13): 1509-1514.
- Frankel S.K, Sullivan E.J, Brown K.K. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Crit Care Clinics. 2002; 18(4): 855-879.
- Swerlick R.A, Lawley T.J. Cutaneous vasculitis: its relationship to systemic disease. Med Clin North Am. 1989; 73(5): 1221-1235.
- Guillevin L, Lhote F, Gherardi R. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin. 1997; 15(4): 865-886.
- Davies D.J, Moran J.E, Niall J.F, Ryan G.B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed). 1982; 285(6342): 606.
- Choi H.K, Liu S, Merkel P.A, Colditz G.A, Niles J.L. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on myeloperoxidase antibodies. J Rheumatol. 2001; 28(7): 1584-1590.
- Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk R.J, Hagen E.C, Jayne D, Jennette J.C, Paspaliaris B, Pollock W, Pusey C, Savage C.O, Silvestrini R, van der Woude F, Wieslander J, Wiik A. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999; 111(4): 507-513.
- Finkielman J.D, Lee A.S, Hummel A.M, Viss M.A, Jacob G.L, Homburger H.A, Peikert T, Hoffman G.S, Merkel P.A, Spiera R, St Clair E.W, Davis J.C. Jr, Mc Cune W.J, Tibbs A.K, Ytterberg S.R, Stone J.H, Specks U; WGET Research Group. ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med. 2007; 120(7): 643. e9-14. 10.1016/j.amjmed.2006.08.016' target='_blank'>https://doi: 10.1016/j.amjmed.2006.08.016
- Mukhtyar C, Guillevin L, Cid M.C, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg C.G, Merkel P.A, Raspe H, Salvarani C, Scott D.G, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009; 68(3): 310-317. https://doi:10. 1136/ard.2008.088096
- Ananthakrishnan L, Sharma N, Kanne J.P. Wegener’s granulomatosis in the chest: high - resolution CT findings. AJR Am J Roentgenol. 2009; 192(3): 676-682. 10.2214/AJR.08.1837' target='_blank'>https://doi: 10.2214/AJR.08.1837
- Hoffman G.S, Kerr G.S, Leavitt R.Y, Hallahan C.W, Lebovics R.S, Travis W.D, Rottem M, Fauci A.S. Wegener’s granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992; 116(6): 488-498.
- Hauer H.A, Bajema I.M, van Houwelingen H.C, Ferrario F, Noël L.H, Waldherr R, Jayne D.R, Rasmussen N, Bruijn J.A, Hagen E.C; European Vasculitis Study Group (EUVAS). Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002; 61(1): 80-89. 10.1046/j.1523-1755.2002' target='_blank'>https://doi: 10.1046/j.1523-1755.2002. 00089.
- Anderson G, Coles E.T, Crane M, Douglas A.C, Gibbs A.R, Geddes D.M, Peel E.T, Wood J.B. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub - committee of the British Thoracic Society Research Committee. Q J Med. 1992; 83(302): 427-438.
- Fauci A.S, Haynes B.F, Katz P, Wolff S.M. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983; 98(1): 76-85.
- Cordier J.F, Valeyre D, Guillevin L, Loire R, Brechot J.M. Pulmonary Wegener’s granulomatosis. A clinical and imaging study of 77 cases. Chest. 1990; 97: 906-912.
- Travis W.D, Hoffman G.S, Leavitt R.Y, Pass H.I, Fauci A.S. Surgical pathology of the lung in Wegener’s granulomatosis. Am J Surg Pathol. 1991; 15(4): 315-333.
- Mark E.J, Flieder D.B, Matsubara O. Treated Wegener’s granulomatosis: distinctive pathological findings in the lung of 20 patients and what they tell us about the natural history of the disease. Hum Pathol. 1997; 28: 450-458.
- Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 2008; 26(Suppl 51): S94-104.
- Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long - term follow - up of 96 patients. Medicine. 1999; 78(1): 26-37.
- Lanham J, Elkon K, Pusey C, Hughes G. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine. 1984; 63: 65-81.
- Comarmond C, Pagnoux C, Khellaf M, Cordier J.F, Hamidou M, Viallard J.F, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L; French Vasculitis Study Group. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long - term follow up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013; 65(1): 270-281. 10.1002/art.37721' target='_blank'>https://doi: 10.1002/art.37721
- Katzenstein A.L. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am J Clin Pathol. 2000; 114(5): 767-772. 10.1309/F3FW-J8EB-X913-G1RJ' target='_blank'>https://doi: 10.1309/F3FW-J8EB-X913-G1RJ
- Keogh K.A, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med. 2003; 115(4): 284-290.
- Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B. Microscopic polyangiitis: clinical and laboratory findings in eighty - five patients. Arthritis Rheum. 1999; 42(3): 421-430. 3.0.CO;2-6'' target='_blank'>10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6' target='_blank'>https://doi: 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6
- Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus. 1998; 7(4): 238-258. 10.1191/096120398678920055' target='_blank'>https://doi: 10.1191/096120398678920055
- Frankel S.K, Cosgrove G.P, Brown K.K. Small vessel vasculitis of the lung. Chron Respir Dis. 2005; 2(2): 75-84. https://doi: 10.1191/ 1479972305cd070rs
- Langford C.A, Talar-Williams C, Sneller M.C. Use of methotrexate and glucocorticoids in the treatment of Wegener’s granulomatosis. Long - term renal outcome in patients with glomerulonephritis. Arthritis Rheum. 2000; 43(8): 1836-1840. 10.1002/1529-0131' target='_blank'>https://doi: 10.1002/1529-0131 (200008)43:8<1836::AID-ANR20>3.0.CO;2-R
- Harper L, Morgan M.D, Walsh M, Hoglund P, Westman K, Flossmann O, Tesar V, Vanhille P, de Groot K, Luqmani R, Flores-Suarez L.F, Watts R, Pusey C, Bruchfeld A, Rasmussen N, Blockmans D, Savage C.O, Jayne D; EUVAS investigators. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long - term follow - up. Ann Rheum Dis. 2012; 71(6): 955-960. 10.1136/annrheumdis-2011-200477' target='_blank'>https://doi: 10.1136/annrheumdis-2011-200477
- Stone J.H, Merkel P.A, Spiera R, Seo P, Langford C.A, Hoffman G.S, Kallenberg C.G, St Clair E.W, Turkiewicz A, Tchao N.K, Webber L, Ding L, Sejismundo L.P, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen N.B, Fervenza F.C, Geetha D, Keogh K.A, Kissin E.Y, Monach P.A, Peikert T, Stegeman C, Ytterberg S.R, Specks U; RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010; 363(3): 221-232. 10.1056/NEJMoa0909905' target='_blank'>https://doi: 10.1056/NEJMoa0909905
- Schmitt W.H, Hagen E.C, Neumann I, Nowack R, Flores-Suárez L.F, van der Woude F.J; European Vasculitis Study Group. Treatment of refractory Wegeners granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int. 2004; 65(4): 1440-1448. 10.1111/j.1523-1755.2004.00534.x' target='_blank'>https://doi: 10.1111/j.1523-1755.2004.00534.x
- Haubitz M, de Groot K. Tolerance of mycophenolate mofetil in end - stage renal disease patients with ANCA-associated vasculitis. Clin Nephrol. 2002; 57(6): 421-424.
- Smith R.M, Jones R.B, Guerry M.J, Laurino S, Catapano F, Chaudhry A, Smith K.G, Jayne D.R. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody - associated vasculitis. Arthritis Rheum. 2012; 64(11): 3760-3769. 10.1002/art.34583' target='_blank'>https://doi: 10.1002/art.34583
- Cohen Tervaert J.W, Stegeman C.A, Kallenberg C.G. Novel therapies for anti - neutrophil cytoplasmic antibody - associated vasculitis. Curr Opin Nephrol Hypertens. 2001; 10(2): 211-217.
- Langford C.A, Sneller M.C. Biologic therapies in the vasculitides. Curr Opin Rheumatol. 2003; 15: 3-10.
- Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne D.R; European Vasculitis Study Group. Brief report: long - term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody - associated vasculitis. Arthritis Rheum. 2012; 64(10): 3472-3477. 10.1002/art' target='_blank'>https://doi: 10.1002/art. 34547
- Seo P, Specks U, Keogh K.A. Efficacy of rituximab in limited Wegener’s granulomatosis with refractory granulomatous manifestations. J Rheumatol. 2008; 35(10): 2017-2023.
- Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Généreau T, Léon A, Bussel A. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty - two patients. Arthritis Rheum. 1995; 38(11): 1638-1645.
- Klemmer P.J, Chalermskulrat W, Reif M.S, Hogan S.L, Henke D.C, Falk R.J. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small - vessel vasculitis. Am J Kidney Dis. 2003; 42(6): 1149-1153.
- Henke D, Falk R.J, Gabriel D.A. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med. 2004; 140(6): 493-494.
- Ahmed S.H, Aziz T, Cochran J, Highland K. Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest. 2004; 126(1): 305-309. 10.1378/chest.126.1.305' target='_blank'>https://doi: 10.1378/chest.126.1.305
- Pagnoux C, Mahr A, Hamidou M.A, Boffa J.J, Ruivard M, Ducroix J.P, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier J.F, Guillevin L; French Vasculitis Study Group. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008; 359(26): 2790-2803. 10.1056/NEJMoa0802311' target='_blank'>https://doi: 10.1056/NEJMoa0802311
- Reinhold-Keller E, Fink C.O, Herlyn K, Gross W.L, De Groot K. High rate of renal relapse in 71 patients with Wegener’s granulomatosis under maintenance remission with low - dose methotrexate. Arthritis Rheum. 2002; 47(3): 326-332. 10.1002/art.10459' target='_blank'>https://doi: 10.1002/art.10459
- Metzler C, Fink C, Lamprecht P, Gross W, Reinhold-Keller E. Maintenance of remission with leflunomide in Wegener’s granulomatosis. Rheumatology (Oxford). 2004; 43(3): 315-320. https://doi.org/ 10.1093/rheumatology/keh009
- Molloy E.S, Langford C.A. Does the dose of methotrexate influence the rate of relapse in patients with Wegener’s granulomatosis? Nat Clin Pract Rheumatol. 2008; 4(1): 12-13. 10.1038/ncprheum0675' target='_blank'>https://doi: 10.1038/ncprheum0675